Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neuropsychiatric symptoms following bismuth intoxication.

Literature DB >> 3186575

Neuropsychiatric symptoms following bismuth intoxication.

M P Weller¹.
1. Friern Hospital, London, UK.

Abstract

A number of seemingly neurotic symptoms, similar to those reported in bismuth intoxication, occurred in a patient taking a proprietary dyspeptic preparation, tri-potassium dicitrate bismuthate (De-Nol), over 2 years. The symptoms remitted over 10-12 months after stopping the drug - a similar period to that described in bismuth intoxication and the patient has remained symptom-free for 7 years. Possible mechanisms are discussed.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1988 PMID： 3186575 PMCID： PMC2428496 DOI： 10.1136/pgmj.64.750.308

Source DB: PubMed Journal: Postgrad Med J ISSN： 0032-5473 Impact factor: 2.401

7 in total

1. [Bismuth encepalopathies. Clinical observations and results of a method of detection of the poison in biologic fluids].

Authors: J P Goullé; A Husson; F Pellerin; F Rapoport; J L Ernoult; L Maunoury; J Sanson; M Samson
Journal: Therapie Date: 1976 Nov-Dec Impact factor: 2.070

2. D-penicillamine does not increase urinary bismuth excretion in patients treated with tripotassium dicitrato bismuthate.

Authors: C U Nwokolo; R E Pounder
Journal: Br J Clin Pharmacol Date: 1990-10 Impact factor: 4.335

3. Neuropsychiatric symptoms following bismuth intoxication.

Authors: G T Eskens
Journal: Postgrad Med J Date: 1988-09 Impact factor: 2.401

Review 4. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

Authors: A J Wagstaff; P Benfield; J P Monk
Journal: Drugs Date: 1988-08 Impact factor: 9.546

Neuropsychiatric symptoms following bismuth intoxication.

1. [Bismuth encepalopathies. Clinical observations and results of a method of detection of the poison in biologic fluids].

2. [Poisoning by orally administered bismuth salts. Epidemiologic survey].

3. Toxic encephalopathy due to ingestion of bismuth salts: clinical and EEG studies of 45 patients.

4. Letter: Mental illness or metal illness? Bismuth subgallate.

5. Mental illness or metal illness? Bismuth subgallate.

6. [Arthropathies due to bismuth poisoning].

7. Reversible encephalopathy possibly associated with bismuth subgallate ingestion.

1. Anomalous short plasma elimination half life in a patient intoxicated with bismuth subcitrate.

2. D-penicillamine does not increase urinary bismuth excretion in patients treated with tripotassium dicitrato bismuthate.

3. Neuropsychiatric symptoms following bismuth intoxication.

Review 4. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

5. Bismuth induced encephalopathy caused by tri potassium dicitrato bismuthate in a patient with chronic renal failure.

Review 6. Adverse effects of drugs used in the management of constipation and diarrhoea.

Review 7. Pharmacokinetics and toxicity of bismuth compounds.